186 related articles for article (PubMed ID: 24020144)
21. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
[TBL] [Abstract][Full Text] [Related]
22. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
[TBL] [Abstract][Full Text] [Related]
23. The impact of multi-modal therapy on survival for uterine carcinosarcomas.
Gonzalez Bosquet J; Terstriep SA; Cliby WA; Brown-Jones M; Kaur JS; Podratz KC; Keeney GL
Gynecol Oncol; 2010 Mar; 116(3):419-23. PubMed ID: 19896181
[TBL] [Abstract][Full Text] [Related]
24. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
Horn LC; Dallacker M; Bilek K
Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
[TBL] [Abstract][Full Text] [Related]
25. [Uterine carcinosarcoma].
Serkies K; Jassem J
Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
[TBL] [Abstract][Full Text] [Related]
26. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
27. Pathologic and molecular features of uterine carcinosarcomas.
Lopez-Garcia MA; Palacios J
Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
[TBL] [Abstract][Full Text] [Related]
28. Carcinosarcoma (malignant mixed müllerian tumor) of the uterus with a rhabdoid tumor component. An immunohistochemical, ultrastructural, and immunoelectron microscopic case study.
Mount SL; Lee KR; Taatjes DJ
Am J Clin Pathol; 1995 Feb; 103(2):235-9. PubMed ID: 7856569
[TBL] [Abstract][Full Text] [Related]
29. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
[TBL] [Abstract][Full Text] [Related]
30. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
[TBL] [Abstract][Full Text] [Related]
31. Impact of multimodal therapy on the survival of patients with newly diagnosed uterine carcinosarcoma.
Machida H; Takahashi K; Nomura H; Matoda M; Omatsu K; Kato K; Umayahara K; Takeshima N
Eur J Gynaecol Oncol; 2013; 34(4):291-5. PubMed ID: 24020131
[TBL] [Abstract][Full Text] [Related]
32. Sarcomatous Component in Uterine Carcinosarcomas Correlates With Advanced Stage and Poorer Prognosis.
Podoll MB; Moghadamfalahi M; Faber E; Bishop JA; Alatassi H
Int J Gynecol Pathol; 2018 Jan; 37(1):22-26. PubMed ID: 28319572
[TBL] [Abstract][Full Text] [Related]
33. Carcinosarcoma of the uterus: a case report and review of the literature.
Spaziani E; Picchio M; Petrozza V; Briganti M; Ceci F; Di Filippo A; Sardella B; De Angelis F; Della Rocca C; Stagnitti F
Eur J Gynaecol Oncol; 2008; 29(5):531-4. PubMed ID: 19051829
[TBL] [Abstract][Full Text] [Related]
34. Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report.
Shen L; Hong L; Zhang G; Mai R
Int J Clin Exp Pathol; 2014; 7(8):5295-301. PubMed ID: 25197413
[TBL] [Abstract][Full Text] [Related]
35. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
36. Presentation and management of carcinosarcoma of the uterus.
Vaccarello L; Curtin JP
Oncology (Williston Park); 1992 May; 6(5):45-9; discussion 53-4, 59. PubMed ID: 1534676
[TBL] [Abstract][Full Text] [Related]
37. Carcinosarcomas of the uterus and ovary: a clinicopathologic and immunohistochemical study of 11 cases.
Kondi-Pafiti A; Grapsa D; Hasiakos D; Gennatas K; Fotiou S
Eur J Gynaecol Oncol; 2009; 30(1):93-7. PubMed ID: 19317268
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
39. [Uterine carcinosarcoma with chondroid differentiation--immuhistochemical examination].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):26-8. PubMed ID: 20198774
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
